Type 2 diabetes (T2D) is a prevalent chronic disease that can result in serious complications including retinopathy, nephropathy and neuropathy. The health problem incurs significant personal and social costs related to treatment and loss of healthy life. Glycaemic control is important in reducing the complications and burden of T2D. It is estimated that in 10 years’ time, one in 10 adults will be living with T2D. Carbohydrate is one of four macronutrients and its intake directly influences glycaemia. Although studies have assessed the impact of various dietary interventions on the management of T2D, there is no specific amount of carbohydrate intake recommended for adults living with T2D. Instead, it is advised that carbohydrate intake, along with the other macronutrients, be assessed based on the current diet, preferences and metabolic goals. Knowing more about the carbohydrate intake of people recently diagnosed with T2D over time in a real-world setting could inform effective and tailored interventions and trials as well as to reduce the costs and impact of T2D.
